J3385 HCPCS code: Injection, velaglucerase alfa, 100 units
J3385 is the HCPCS Level II code for injection, velaglucerase alfa, 100 units. In 2024 Medicare paid an average of $282.16 per service for J3385 across 34,872 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 80 per day on outpatient hospital claims. Medicare volume rose 22% from 2022 to 2024 (28,513 to 34,872 services). In 2024, about 114 clinicians billed Medicare for J3385 for 43 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2011-01-01 |
| Last action effective | 2011-01-01 |
Who bills J3385 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 114 |
| Medicare beneficiaries | 43 |
| States with claims | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3385, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 28,513 | 42 | $355.74 | $283.74 |
| 2023 | 34,285 | 44 | $351.95 | $280.33 |
| 2024 | 34,872 | 43 | $354.30 | $282.16 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 80 | Clinical: Data |
| practitioner claims | 80 | Clinical: Data |
What changed for J3385
- 2011-01-01: J3385 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3385?
J3385 is the HCPCS Level II code for injection, velaglucerase alfa, 100 units. Short descriptor: "Velaglucerase alfa".
How much does Medicare pay for J3385?
In 2024, the average Medicare payment was $282.16 per service (average allowed $354.30).
Does Medicare cover J3385?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3385 can be billed per day?
80 on outpatient hospital claims; 80 on practitioner claims (NCCI medically unlikely edits).
Related J33 codes
- J3300 — Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
- J3301 — Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302 — Injection, triamcinolone diacetate, per 5 mg
- J3303 — Injection, triamcinolone hexacetonide, per 5 mg
- J3304 — Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3305 — Injection, trimetrexate glucuronate, per 25 mg
- J3310 — Injection, perphenazine, up to 5 mg
- J3315 — Injection, triptorelin pamoate, 3.75 mg
- J3316 — Injection, triptorelin, extended-release, 3.75 mg
- J3320 — Injection, spectinomycin dihydrochloride, up to 2 gm
- J3350 — Injection, urea, up to 40 gm
- J3355 — Injection, urofollitropin, 75 iu
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3385
- Watch J3385 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3385
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.